MONTREAL, QUEBEC, CANADA -- (MARKET WIRE) -- 12/14/07 -- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announced today that it has closed on the draw down ("Draw Down") with Nanuq Investments Ltd.
("Nanuq") that was filed on December 6, 2007. 610,968 subordinate voting shares ("Subordinate Shares") were issued to Nanuq at an average price above $0.57 per subordinate share for gross proceeds of C$350,000. Details of the draw down are set out in a pricing supplement ("Supplement") dated December 14, 2007 to a short form base shelf prospectus ("Prospectus") dated November 3, 2006, as amended and supplemented, available at the SEDAR website at
www.sedar.com.

"As stated previously, this Facility offers us the flexibility to draw on funds when the market conditions are optimal for ProMetic, hence providing the Company with the ability to control the amount of money it wishes to draw while maximizing on ProMetic's higher share price," stated Mr. Pierre Laurin, President and Chief Executive Officer of ProMetic.

About ProMetic Life Sciences Inc.
ProMetic Life Sciences Inc. (www.prometic.com) is a biopharmaceutical
company specialized in the research, development, manufacture and
marketing of a variety of commercial applications derived from its
proprietary Mimetic Ligand(TM) technology. This technology is used in
large-scale purification of biologics and the elimination of
pathogens. ProMetic is also active in therapeutic drug development
with the mission to bring to market effective, innovative, lower
cost, less toxic products for the treatment of hematology and cancer.
Its drug discovery platform is focused on replacing complex,
expensive proteins with synthetic "drug-like" protein mimetics.
Headquartered in Montreal (Canada), ProMetic has R&D facilities in
the U.K., the U.S. and Canada, manufacturing facilities in the U.K.
and business development activities in the US, Europe, Asia and in
the Middle-East.

Contacts:
Company Inquiries
ProMetic Life Sciences Inc.
Pierre Laurin
President and CEO
+1-514-34-2115
p.laurin@prometic.com

ProMetic Life Sciences Inc
Anne Leduc
Manager, Communications
+1-514-341-2115
a.leduc@prometic.com